Clinical Trial Update: Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a symptomatic treatment for perennial allergic rhinitis has completed, including a one-year safety extension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Snippet

Sponsor: Faes Farma, S.A. | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED